Loading...
•
Sep 30, 2023
Penumbra Q3 2023 Earnings Report
Penumbra reported strong Q3 2023 results with significant revenue growth and increased profitability.
Key Takeaways
Penumbra, Inc. reported a 26.8% increase in revenue to $270.9 million for Q3 2023, driven by strong growth in thrombectomy products. The company achieved a net income of $9.2 million and an adjusted EBITDA of $51.5 million.
Revenue increased by 26.8% to $270.9 million compared to Q3 2022.
Thrombectomy product sales grew by 38.0% to $179.1 million.
Net income was $9.2 million, with an adjusted EBITDA of $51.5 million.
The company expects revenue growth to accelerate to 28% to 31% year over year for Q4 2023.
Revenue by Segment
Revenue by Geographic Location
Forward Guidance
The company expects total company revenue growth to accelerate to 28% to 31% year over year for the fourth quarter of 2023, correlating to the midpoint of the annual guidance range of $1.05 billion to $1.07 billion for full year 2023.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...